Skip to main content
logo
XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8610
-0.0390 (-4.33%)
At close: Nov 19, 2025, 4:00 PM EST
0.8775
+0.0165 (1.92%)
Pre-market: Nov 20, 2025, 4:21 AM EST

XTL Biopharmaceuticals Revenue

In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K. XTL Biopharmaceuticals had revenue of $405.00K in the quarter ending December 31, 2024.

Revenue (ttm)
$451.00K
Revenue Growth
n/a
P/S Ratio
18.48
Revenue / Employee
$45,100
Employees
10
Market Cap
8.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024451.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

XTLB News

More News